Abstract
Aim
To investigate whether two methods of measuring macular pigment—namely, heterochromatic flicker photometry (HFP) and resonance Raman spectroscopy (RRS)—yield comparable data.
Methods
Macular pigment was measured using HFP and RRS in the right eye of 107 participants aged 20–79 years. Correlations between methods were sought and regression models generated. RRS was recorded as Raman counts and HFP as macular pigment optical density (MPOD). The average of the top three of five Raman counts was compared with MPOD obtained at 0.5° eccentricity, and an integrated measure (spatial profile; MPODsp) computed from four stimulus sizes on HFP.
Results
The coefficient of variation was 12.0% for MPODsp and 13.5% for Raman counts. MPODsp exhibited significant correlations with Raman counts (r = 0.260, p = 0.012), whereas MPOD at 0.5° did not correlate significantly (r = 0.163, p = 0.118). MPODsp was not significantly correlated with age (p = 0.062), whereas MPOD at 0.5° was positively correlated (p = 0.011). Raman counts showed a significant decrease with age (p = 0.002) and were significantly lower when pupil size was smaller (p = 0.015).
Conclusions
Despite a statistically significant correlation, the correlations were weak, with those in excess of 90% of the variance between MPODsp and Raman counts remaining unexplained, meriting further research.
Macular pigment is composed of the oxycarotenoids lutein and zeaxanthin. These pigments are potent antioxidants, which are thought to protect the retina and other adjacent tissues from the damaging effects of oxidative stress and thus limit ageing or other degenerative processes.1,2,3,4,5,6 Two psychophysical methods have been used to measure macular pigment in vivo—namely, heterochromatic flicker photometry (HFP)7,8 and minimum motion photometry9—as well as several physical methods, such as fundus reflectometry,10 autofluorescence spectrometry11 and resonance Raman spectroscopy (RRS).12
Currently, the most widely used method of measuring macular pigment is HFP. The advantages cited by its proponents are relatively inexpensive instrumentation, absence of necessity for pupillary dilatation, relative robustness to changes in ocular media that accompany increasing age, and the short period required to train operators to achieve reliable results.13 However, the patient typically needs to be alert and cooperative, and as central fixation is essential, good visual acuity is required. These disadvantages limit the use of HFP in elderly populations in whom robust reliable estimates of macular pigment are most needed to identify putative links between altered macular pigment and macular disease.
RRS is a more recently developed alternative, and this technique provides an objective, rapid, sensitive, specific and highly reproducible method for estimating macular pigment in patients with a wide variety of macular pathological features as long as they retain central fixation.14,15,16 However, features of normal ageing such as senile miosis and lens opacity are known to degrade the Raman spectra and may also limit its application in cohorts of elderly people.14 The present study was designed to compare HFP and RRS in healthy adults from a wide age range, and the results of this comparison are presented.
Participants and methods
Participants
All procedures were carried out according to published protocols and none of the authors had any proprietary interest in either technique. Informed consent was obtained from all participants. The research ethics committee of the Faculty of Medicine, Queen's University of Belfast, Belfast, UK, approved the study design. The study adhered strictly to the tenets of the Declaration of Helsinki on research on human volunteers. Participants were contacted via their general medical practitioners, or by means of posters and leaflets distributed throughout the hospital. Those eligible for screening were men and women aged >20 years, without a history of major ocular disease (uveitis, glaucoma, diabetes, macular degeneration, amblyopia, retinal detachment or ocular trauma). Cataract was not an exclusion criterion, but as the visual acuity cut‐off for the study was 0.1 logarithm of the minimum angle of resolution (LogMAR) (20/25), the presence of any major medial opacity in eligible participants was highly unlikely.
Heterochromatic flicker photometry
HFP is based on psychophysical brightness matching principles.7,8 It requires the patient to adjust a flickering stimulus to a point of minimum flicker or no flicker, while first fixating foveally and then parafoveally (7°). As macular pigment absorbs blue light, the perception of flicker is altered by pigment concentration, thus allowing an estimate of the macular pigment optical density (MPOD) to be made. The machine used was an early version of the HFP densitometer and was on loan to us from Macular Metrics, Rehoboth, Massachusetts, USA.8 The protocol we used was based on the methods developed and validated for the Carotenoids and Age Related Eye Disease Study (CAREDS).13 As the instrument on loan differed slightly from that used in CAREDS, minor changes in the protocol were needed. The instrument was set up to test only the right eye, and hence only right eyes were study eyes.
Four test field configurations were used to enable a spatial profile to be drawn. The first three stimuli were centred on the fovea, and the stimulus appearance and sizes were (a) solid disc 10′ arc radius, (b) solid disc 0.5° arc radius, (c) annulus 1° arc radius and (iv) solid disc 0.5° arc radius centred 2° from fixation providing an eccentricity of 2.5°. After several practice runs, four different determinations of the point of minimal flicker were made for each target.
Resonance Raman spectroscopy
The Raman spectroscope was purchased from Spectrotek LC, Salt Lake City, Utah, USA. The principles and protocol for best practice of RRS have been described in detail by Bernstein et al.14,15,16 It is a relatively new technique that exploits the inherent property of lutein and zeaxanthin to produce resonance Raman spectra when stimulated using 488‐nm argon laser light. Pupillary dilatation was achieved using tropicamide (Minims, Charvin Pharmaceuticals Ltd, UK) 1% for those aged <50 years or a combination of cyclopentolate 1% and phenylephrine 2.5% for those aged >50 years to ensure maximum dilatation.17 Pupil size was recorded to the nearest 0.5 mm using a millimetre rule after maximum dilatation. Raman signal intensity is expressed as photon counts. To overcome errors introduced by misalignment or blink, the manufacturers advise that the highest three of the five measurements recorded at any one sitting be used for statistical analysis.
For assessment of variability, HFP using all the stimulus sizes and Raman counts were measured on 11 volunteers who attended four times over a 2‐week period.
Clinical evaluations
Best‐corrected visual acuity was recorded in each eye separately using the Early Treatment Diabetic Retinopathy Study (ETDRS) logarithm of the minimum angle of resolution charts at 4 m, and the anterior segment was clinically assessed by slit‐lamp biomicroscopy. The status of the crystalline lens of each eye was recorded after comparison with Lens Opacities Classification System II standards.18 Iris colour was recorded as brown, intermediate or blue using the European Eye Study (EUREYE) standards.19 A history of cigarette smoking, which is considered to be a risk factor for low macular pigment, was obtained.20
Photographic and grading procedures
All photographs were taken using the Topcon TRC 50 EX acquisition system with imageNET2000, V.2.53, Digital Imaging systems (Topcon, UK). A single anterior segment image of each eye was taken after full pupillary dilatation. The diameters of the dilated pupil and the cornea were measured using the measurement tool on the imageNET software. For fundus grading, a pair of 35° images of field 2 were captured (Wisconsin Age‐Related Maculopathy Grading System).21 The fundus images were graded using standardised protocols based on the definitions provided by the Wisconsin Age‐Related Maculopathy Grading system.21
Definitions and statistical analysis
We used two HFP parameters in the analysis. The first parameter was the MPOD from the 0.5° arc radius (MPOD0.5), which we used because it was shown to have the best within‐to‐between‐subject variation.13 The second parameter was the area under the spatial profile curve (MPODsp), which was plotted using the right eye measurements from all four targets where the x axis (angle) was transformed logarithmically to avoid overinfluence of results at large angles. Calculation of the area under the curve was based on the trapezium rule, with no extrapolation made for any areas beyond that bounded by the measurements.
The diameter of the laser beam at the pupil was 7 mm. To prevent its absorption by the iris, we excluded the data from participants whose pupils were <7 mm. in line with the recommendations of the manufacturers of Raman spectroscope,14,15,16,22 Pupillary diameter was measured using a millimetre rule, which is a crude measurement. Therefore, we also measured pupillary diameter from the anterior segment image. As image magnification can vary with camera focusing, we derived the pupillary diameter:corneal diameter ratio. Linear regression was undertaken using pupil size measured on the millimetre rule as the dependent variable, and pupillary diameter and pupillary diameter:corneal diameter ratio as independent variables. The unstandardised predicted values from the model were saved and used as the surrogate measurement for pupil size. This method works on the assumption that both techniques of measuring pupillary diameter are prone to measurement error, but that this error may be minimised by using a third variable that is a composite of the two methods. We termed this variable the predicted pupil size (PPS).
Data were analysed using SPSS V.10. The RRS data were found to be skewed and were therefore log transformed to assume a normal distribution and enable comparison with MPOD, which is a logarithmic measure. Data obtained from the 11 participants (7 women, 4 men, age range 21–50 years) who returned four times over a 2‐week period were used to construct a components of variance model to calculate coefficients of variation for between‐visit repeatability for both methods. The coefficient of variation was expressed as a percentage. Pearson's correlation coefficients were calculated to investigate the relationship between average Raman and the two HFP variables (MPOD0.5, MPODsp). A series of regression analyses were run with average Raman, MPOD 0.5 and MPODsp as the dependent variables and age as the independent variable. Linear regression using backward stepwise elimination was applied to examine relationships between average Raman (dependent variable) and age, sex, iris colour, pupil size, smoking history, lens and age‐related maculopathy status as independent variables.
Results
Participant demographics
A total of 107 people (69 women, 38 men), ranging in age from 20 to 79 years (mean 42 years), participated in the study. Data from HFP recordings from four participants were deemed unreliable, as the standard deviation of 0.5° arc radius stimulus determination exceeded 0.20; therefore data from 103 participants were available for univariate analysis. In nine participants pupillary dilatation failed to reach the specified value, and data from these were excluded from all analyses. Raman counts could not be obtained from one participant owing to equipment failure. Therefore Raman counts from 93 participants were available for univariate analysis. After accounting for all exclusions, 93 sets (HFP and Raman counts) were available for the bivariate analysis. Table 1 gives a summary of the demographic findings, participant numbers and the effect of categorisation by sex, smoking status, iris colour, and decade of age on mean MPOD0.5 and average Raman. Mean (standard deviation (SD)) MPOD0.5 was 0.38 (0.18). The mean of the average Raman was 1048 (SD 435).
Table 1 Average Raman and MPOD0.5 stratified by participant characteristics.
| RRS | HFP | |||||
|---|---|---|---|---|---|---|
| Participants (n = 97) | AR* | SD | Participants (n = 103) | MPOD0.5† | SD | |
| Overall | 97 | 1048 | 435 | 103 | 0.38 | 0.18 |
| Men | 34 | 1122 | 478 | 37 | 0.38 | 0.19 |
| Women | 63 | 1008 | 408 | 66 | 0.39 | 0.18 |
| Iris | ||||||
| Blue | 66 | 1033 | 448 | 72 | 0.38 | 0.18 |
| Intermediate | 15 | 1120 | 385 | 15 | 0.37 | 0.21 |
| Brown | 16 | 1039 | 445 | 16 | 0.41 | 0.13 |
| Smoking status | ||||||
| Current smoker | 9 | 823 | 396 | 10 | 0.34 | 0.14 |
| Non‐smoker | 85 | 1073 | 434 | 82 | 0.38 | 0.19 |
| Age (years) | ||||||
| 20–29 | 34 | 1220 | 459 | 35 | 0.34 | 0.18 |
| 30–39 | 19 | 1060 | 459 | 20 | 0.39 | 0.18 |
| 40–49 | 15 | 907 | 456 | 16 | 0.36 | 0.16 |
| 50–59 | 13 | 1058 | 347 | 15 | 0.41 | 0.17 |
| 60–69 | 14 | 784 | 329 | 14 | 0.44 | 0.20 |
| 70–79 | 2 | 837 | 203 | 3 | 0.53 | 0.07 |
| >60 | 16 | 791 | 311 | 17 | 0.46 | 0.17 |
| Lens status | ||||||
| 0 | 81 | 1082 | 451 | 86 | 0.38 | 0.18 |
| 1 | 2 | 1006 | 469 | 2 | 0.39 | 0.24 |
| 2 | 8 | 946 | 272 | 8 | 0.48 | 0.14 |
| 3 | 6 | 729 | 258 | 7 | 0.39 | 0.16 |
| No drusen or just hard drusen | 94 | 1050 | 438 | 98 | 0.38 | 0.17 |
| Soft distinct drusen | 2 | 953 | 544 | 4 | 0.53 | 0.25 |
| No drusen, focal pigment present | 1 | 974 | 0 | 1 | 0.34 | ‐ |
AR, average Raman (the average of the top three counts from each participant); HFP, heterochromatic flicker photometry; MPOD0.5, macular pigment optical density measured at 0.5°arc radius; RRS, resonance Raman spectroscopy.
*Mean Raman counts from groups of participants.
†Data represent the average of four independent readings per participant.
Repeatability
Of the 11 participants, seven were women and four were men; the average age of the participants was 31.5 (range 21–50) years. The components of variance model showed that MPODsp exhibited less between‐visit variability (12.0%) when compared with average Raman (13.5%); and the 0.5° arc radius stimuli showed the least variability (11.5%; table 2).
Table 2 Between‐visit repeatability in measurements by resonance Raman spectroscopy and heterochromatic flicker photometry.
| Variable | Between‐visit coefficient of variation (%) |
|---|---|
| HFP | 13.0 |
| 10′ arc radius | |
| 0.5° arc radius | 11.5 |
| 1° arc radius | 33.0 |
| 2.5° arc radius | 54.0 |
| Spatial profile | 12.0 |
| RRS | |
| Average Raman | 13.5 |
RRS, resonance Raman spectroscopy; HFP, heterochromatic flicker photometry.
Correlations between MPOD and Raman counts
MPOD0.5 did not significantly correlate with average Raman (r = 0.163, p = 0.118), whereas MPODsp was significantly correlated (r = 0.260, p = 0.012). The correlations were weak, with those in excess of 90% of the variance between MPODsp and Raman counts remaining unexplained. A scatter plot of MPODsp and average Raman (fig 1) shows this relationship.
Figure 1 Relationship between heterochromatic flicker photometry and average Raman. Although the scatter plot shows a considerable degree of variation, a significant correlation between the two methods (R = 0.260, p = 0.01) is evident.
Influence of age on MPOD and Raman counts
Regression analyses with age as the independent variable and each of the two HFP parameters and average Raman entered as the sole dependent variable into three separate models showed that MPODsp was not significantly correlated with age. MPOD0.5 had a weak significant positive correlation (table 3), and average Raman showed a significant negative correlation with increasing age.
Table 3 Regression models examining relationships between age and heterochromatic flicker photometry and resonance Raman spectroscopy parameters.
| Dependent variable | Adjusted R2 | Regression coefficient | t Statistic | p Value |
|---|---|---|---|---|
| Average Raman | 0.091 | −0.010 | −3.27 | 0.002 |
| MPODsp | 0.025 | 0.002 | 1.89 | 0.062 |
| MPOD0.5 | 0.052 | 0.003 | 2.58 | 0.011 |
MPOD0.5, macular pigment optical density measured at the 0.5°arc radius; MPODsp, macular pigment optical density spatial profile.
Relationships between putative risk factors and average Raman and HFP parameters
Multiple linear regression with backward stepwise elimination in a model with average Raman as the dependent variable and age, sex, iris colour, PPS, smoking status, lens status and age‐related maculopathy status as independent variables yielded age and PPS as the most significant parameters (model 1, table 4). All other parameters were rejected by the model. Apart from age, none of the parameters reached significance when a similar model was run with MPOD0.5 as the dependent variable (model 2, table 4). In model 1, after exclusion of non‐significant independent variables, the final model (shown by *) included only age and PPS with an adjusted R2 = 0.138. In model 2, after exclusion of non‐significant independent variables, the final model (shown by *) included only age with an adjusted R2 = 0.052.
Table 4 Parameter estimates from two regression models examining the relationships between putative risk factors and the two methods of macular pigment estimation.
| Independent variables | Model 1: average Raman | Model 2: MPOD0.5 | ||||
|---|---|---|---|---|---|---|
| Regression coefficient | t Statisitc | p Value | Regression coefficient | t Statistic | p Value | |
| Age | −0.010 | −2.30 | 0.02 | 0.004 | 2.63 | 0.01 |
| Sex | −0.043 | −0.43 | 0.67 | 0.037 | −0.67 | 0.50 |
| Iris colour | 0.031 | 0.50 | 0.62 | 0.012 | 0.51 | 0.61 |
| PPS | 0.224 | 2.10 | 0.04 | — | — | — |
| Smoking history | 0.092 | 1.22 | 0.23 | 0.046 | 1.59 | 0.12 |
| Lens status | 0.055 | 0.761 | 0.45 | −0.025 | −0.94 | 0.35 |
| Age‐related maculopathy status | 0.163 | 0.85 | 0.40 | 0.042 | 0.64 | 0.52 |
| Age* | −0.008* | −2.69* | 0.009* | 0.002* | 2.73* | 0.007* |
| PPS* | 0.253* | 2.47* | 0.015* | |||
AR, average Raman; MPOD0.5, macular pigment optical density measured at 0.5° arc radius.
*The final model after exclusion of non‐significant variables.
Discussion
Many studies using HFP have found MPOD to lie in the range 0.21–0.47.23,24,25,26,27 The mean MPOD0.5 in our population was within this range and closest to that reported in CAREDS (0.38 in the present study v 0.42 in CAREDS). The mean Raman counts in the present study (1048) are similar to those in another study that used an identical instrument (1118).28
The present study was designed to examine the strength of the relationships between the two methods of measuring macular pigment—namely, HFP and Raman spectroscopy—through undertaking both sets of tests on the same eye of the sample population on the same day. We found a statistically significant correlation only between the MPODsp HFP parameter and average Raman, whereas the correlation between average Raman and MPOD0.5 was close to significance. It was evident, however, that the relationships were disappointingly weak, with substantial discordance detected between methods. The slightly stronger correlation noted between MPODsp and average Raman is intuitively in keeping with the nature of the RRS signal as it collects the back scatter from the retinal area covered by the 1‐mm‐diameter laser spot. It is therefore likely to correlate better with the HFP parameter that provides an integrated estimate of the area under the curve reflecting the spatial profile of macular pigment.
The present work is not in accord with another recent study that undertook a similar validation of the RRS against a flicker‐based method.28 Neelam et al28 reported that MPOD measured by HFP and Raman counts obtained on RRS showed good correlations. By contrast, in the present study, correlations between these methods were poor. The following are the possible reasons for this discrepancy:
The maculometer used by Neelam et al,28 although based on HFP principles, did not have the ability to optimise the flicker rate which is crucial for accurately defining the null zone and thus reliability.23 Critical flicker frequency is influenced by both age29,30,31 and MPOD levels,32 necessitating its determination in each participant to prevent confounding.
Neelam et al based their conclusions on the use of Bland and Altman plots, which simply measure agreement between methods rather than correlations. Notably, correlations can be poor despite good agreement shown by Bland and Altman plots.
Neelam et al converted Raman counts arbitrarily to optical density measurements to enable comparison with MPOD using Bland and Altman methods. Given the radically different scientific principles that underlie the two methodologies (HFP and RRS), we believe it inappropriate to convert Raman counts to MPOD.
Neelam et al28 also state that MPOD and Raman counts in their sample population showed the same relationships with age, sex and serum concentrations of lutein and zeaxanthin, thus authenticating RRS as a valid method of measuring macular pigment. In the present study, with a sample whose upper age limit was 79 years, we found that MPOD and Raman counts showed differential relationships with age. MPOD0.5 showed a small positive correlation with age, MPODsp was unrelated to age and Raman counts reduced significantly with increasing age. Our findings are consistent with the majority of the literature in this discipline, which show that MPOD does not change with increasing age,11,23,24 whereas Raman counts decline with age even after participants with insufficient pupil dilatation were excluded.16,33 Also supporting an absence of an association between MPOD and age are the findings of biochemical analysis of autopsy samples.34
The correlations between RRS and HFP are notably lower than those found in studies that have compared HFP with other physical methods of measuring macular pigment, where intermethod correlations range from 0.4235 to 0.77.11 One possible explanation for the discordant results when comparing flicker‐based methods and RRS is the attenuation of the Raman signal by an age‐related increase in lens optical density as a result of yellowing.36,37,38 The input and output signals of the RRS laser are within the wavelengths absorbed by the crystalline lens, and individual differences in absorption may differentially attenuate the signal. Although yellowing increases with age,36,37,38 the variation between individuals is substantial, meaning that a simple age‐related correction factor would not reliably compensate for the attenuation. Although nuclear colour was evaluated using Lens Opacities Classification System II classification, it is not a reliable measure of yellowing. Therefore, differences in short‐wavelength absorption may be present, although the lens may seem clear from a clinical perspective. This important factor that influences Raman signal intensity may account for some of the age‐related decline in macular pigment when measured by this method.
Our analysis also showed that the Raman signal was adversely influenced by the pupillary diameter even in eyes with diameters ⩾7 mm. This finding is not in agreement with that of Neelam et al,17 who reported that the age‐related decline in Raman counts was dramatically attenuated to non‐significance on exclusion of participants with a pupil size <7 mm. The differences between the present study and that of Neelam et al17 may be related to the technique used to measure pupillary diameter. Although we also used a millimetre rule to determine a cut‐off for inclusion or exclusion, we accepted that this is likely to lead to measurement error. Therefore, in the present study, the corneal diameter:pupillary diameter ratio along with the pupillary diameter measured on the millimetre rule was used to derive a more robust measurement, thereby improving the validity and reliability of the data.
Head stabilisation and alignment are also critical for the optimisation of the Raman signal, and may contribute to recording noise and account for the differences in the methods.39,40 These factors are particularly pertinent in those participants whose pupil diameter is close to the 7‐mm limit, where alignment is much more critical to ensure that the laser beam is not impeded by the iris as it traverses the anterior segment.
In conclusion, although a small significant correlation between MPOD and Raman counts suggests that a relationship exists between measurements by HFP and RRS, our study has shown that these two methods of measuring macular pigment in vivo cannot as yet be used as surrogates for each other.
Acknowledgements
We thank Randy Hammond, Max Snodderly and Billy Wooten for providing access to a heterochromatic flicker photometer, as well as for advice and training, and Paul Bernstein and Werner Gellermann for advice and training in in vivo RRS.
Abbreviations
CAREDS - Carotenoids and Age Related Eye Disease Study
HFP - heterochromatic flicker photometry
LogMAR - logarithm of the minimum angle of resolution
MPOD - macular pigment optical density
MPOD0.5 - macular pigment optical density measured at the 0.5°arc radius
MPODsp - macular pigment optical density spatial profile
PPS - predicted pupil size
RRS - resonance Raman spectroscopy
Footnotes
Funding: This study was funded by grants from The Health Foundation and Evi‐Genoret.
Competing interests: None.
References
- 1.VandenLangenberg G M, Mares‐Perlman J A, Klein R.et al Associations between antioxidant and zinc intake and the 5‐year incidence of early age‐related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998148204–214. [DOI] [PubMed] [Google Scholar]
- 2.Mares‐Perlman J A, Fisher A I, Klein R.et al Lutein and zeaxanthin in the diet and serum and their relation to age‐related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol 2001153424–432. [DOI] [PubMed] [Google Scholar]
- 3.Seddon J M, Ajani U A, Sperduto R D.et al Dietary carotenoids, vitamins A, C, and E, and advanced age‐related macular degeneration. Eye Disease Case‐Control Study Group. JAMA 19942721413–1420. [PubMed] [Google Scholar]
- 4.Eye Disease Case‐Control Study Group Antioxidant status and neovascular age‐related macular degeneration. Arch Ophthalmol 1993111104–109. [DOI] [PubMed] [Google Scholar]
- 5.Gale C R, Hall N F, Phillips D I W.et al Lutein and zeaxanthin status and risk of age‐related macular degeneration. Invest Ophthalmol Vis Sci 2003442461–2465. [DOI] [PubMed] [Google Scholar]
- 6.Snellen E L, Verbeek A L, Van Den Hoogen G W.et al Neovascular age‐related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 200280368–371. [DOI] [PubMed] [Google Scholar]
- 7.Werner J S, Donnelly S K, Kliegl R. Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 198727257–268. [DOI] [PubMed] [Google Scholar]
- 8.Wooten B R, Hammond B R, Jr, Land R I.et al A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999402481–2489. [PubMed] [Google Scholar]
- 9.Robson A G, Moreland J D, Pauleikhoff D.et al Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res 2003431765–1775. [DOI] [PubMed] [Google Scholar]
- 10.Berendschot Tos T J M, Willemse‐Assink J J M, Bastiaanse M.et al Macular pigment and melanin in age‐related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002431928–1932. [PubMed] [Google Scholar]
- 11.Delori F C, Goger D G, Hammond B R.et al Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt. Image Sci Vis 2001181212–1230. [DOI] [PubMed] [Google Scholar]
- 12.Bernstein P S, Zhao D, Sharifzadeh M.et al Resonance Raman measurement of macular carotenoids in the living human eye. Arch Biochem Biophys 2004430163–169. [DOI] [PubMed] [Google Scholar]
- 13.Snodderly D M, Mares J A, Wooten B R.et al Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age‐related eye disease study. Invest Ophthalmol Vis Sci 200445531–538. [DOI] [PubMed] [Google Scholar]
- 14.Gellermann W, Ermakov I V, Ermakova M R.et al In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A Opt Image Sci Vis 2002191172–1186. [DOI] [PubMed] [Google Scholar]
- 15.Bernstein P S, Yoshida M D, Katz N B.et al Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 1998392003–2011. [PubMed] [Google Scholar]
- 16.Bernstein P S, Zhao D, Wintch S W.et al Resonance Raman measurement of macular carotenoids in normal subjects and in age‐related macular degeneration patients. Ophthalmology 20021091780–1787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Levine L. Mydriatic effectiveness of dilute combinations of phenylephrine and tropicamide. Am J Optom Physiol Opt 198259580–594. [DOI] [PubMed] [Google Scholar]
- 18.Chylack L T, Jr, Leske M C, McCarthy D.et al Lens opacities classification system II (LOCS II). Arch Ophthalmol 1989107991–997. [DOI] [PubMed] [Google Scholar]
- 19.Augood C, Fletcher A, Bentham G.et al Methods for a population‐based study of the prevalence of and risk factors for age‐related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol 200411117–129. [DOI] [PubMed] [Google Scholar]
- 20.Hammond B R, Jr, Wooten B R, Snodderly D M. Cigarette smoking and retinal carotenoids: implications for age‐related macular degeneration. Vision Res 1996363003–3009. [DOI] [PubMed] [Google Scholar]
- 21.Klein R, Davis M D, Magli Y L.et al The Wisconsin age‐related maculopathy grading system. Ophthalmology 1991981128–1134. [DOI] [PubMed] [Google Scholar]
- 22.Ermakov I V, McClane R W, Gellerman W.et al Resonant Raman detection of macular pigment levels in the living human retina. Opt Lett 200126202–204. [DOI] [PubMed] [Google Scholar]
- 23.Mellerio J, Ahmadi‐Lari S, van Kuijk F.et al A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 20022537–47. [DOI] [PubMed] [Google Scholar]
- 24.Ciulla T A, Hammond B R., Jr Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age‐related macular degeneration. Am J Ophthalmol 2004138582–587. [DOI] [PubMed] [Google Scholar]
- 25.Hammond B R, Jr, Caruso‐Avery M. Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 2000411492–1497. [PubMed] [Google Scholar]
- 26.Ciulla T A, Curran‐Celantano J, Cooper D A.et al Macular pigment optical density in a midwestern sample. Ophthalmology 2001108730–737. [DOI] [PubMed] [Google Scholar]
- 27.Beatty S, Murray I J, Henson D B.et al Macular pigment and risk for age‐related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 200142439–446. [PubMed] [Google Scholar]
- 28.Neelam K, O'Gorman N, Nolan J.et al Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry. Invest Ophthalmol Vis Sci 2005461023–1032. [DOI] [PubMed] [Google Scholar]
- 29.Tyler C W. Two processes control variations in flicker sensitivity over the life span. J Opt Soc Am A 19896481–490. [DOI] [PubMed] [Google Scholar]
- 30.Lachenmayr B J, Kojetinsky S, Ostermaier N.et al The different effects of aging on normal sensitivity in flicker and light‐sense perimetry. Invest Ophthalmol Vis Sci 1994352741–2748. [PubMed] [Google Scholar]
- 31.Haegerstrom‐Portnoy G, Schneck M E, Brabyn J A. Seeing into old age: vision function beyond acuity. Optom Vis Sci 199976141–158. [DOI] [PubMed] [Google Scholar]
- 32.Hammond B R, Jr, Wooten B R. CFF thresholds: relation to macular pigment optical density. Ophthalmic Physiol Opt 200525315–319. [DOI] [PubMed] [Google Scholar]
- 33.Zhao D Y, Wintch S W, Ermakov I V.et al Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies. Arch Ophthalmol 2003121967–972. [DOI] [PubMed] [Google Scholar]
- 34.Bone R A, Landrum J T, Fernandez L.et al Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 198829843–849. [PubMed] [Google Scholar]
- 35.Berendschot T T, van Norren D. On the age dependency of the macular pigment optical density. Exp Eye Res 200581602–609. [DOI] [PubMed] [Google Scholar]
- 36.Pokorny J, Smith V C, Lutze M. Aging of the human lens. Appl Opt 1987261437–1440. [DOI] [PubMed] [Google Scholar]
- 37.Xu J, Pokorny J, Smith V C. Optical density of the human lens. J Opt Soc Am A Opt Image Sci Vis 199714953–960. [DOI] [PubMed] [Google Scholar]
- 38.Savage G, Haegerstrom‐Portnoy G, Adams A J.et al Age changes in the optical density of human ocular media. Clin Vis Sci 1993897–108. [Google Scholar]
- 39.Wooten B R, Hammond B R., Jr Assessment of the Raman method of measuring human macular pigment [electronic letter]. Invest Ophthalmol Vis Sci. 2003 http://www.iovs.org/cgi/eletters?lookup = by_date&days = 9999#73 (accessed 1 Jul 2004)
- 40.Bernstein P S, Gellermann W. Author response: assessment of the Raman method of measuring human macular pigment [electronic letter]. Invest Ophthalmol Vis Sci. http://www.iovs.org/cgi/eletters?lookup = by_date&days = 9999#74 (accessed 1 Jul 2004)

